Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giancarlo Valenti

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Canadian Family Physician Medecin De Famille Canadien|December 17, 2008
Question: can you identify this condition?Claudio Guarneri, Giancarlo Valenti
Journal of Hospital Medicine|April 16, 2010
More than a plantar wartClaudio Guarneri, Giancarlo Valenti
Dermatology Reports|July 3, 2024
Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussionGaia Fasano, Giancarlo Valenti, Domenico D'Amico, et al.
Dermatologic Therapy|October 1, 2022
A severe case of IgA bullous pemphigoid successfully treated with dupilumabMario Valenti, Pierfrancesco De Giacomo, Annamaria Lavecchia, et al.
Clinical and Experimental Dermatology|April 25, 2026
Real-world efficacy and safety of Sonidegib in Locally Advanced and Multiple Basal Cell Carcinomas: A Monocentric Prospective Observational StudyChiara Del Re, Vincenzo Filastro, Gaia Fasano, et al.
American Journal of Clinical Dermatology|April 24, 2014
Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian populationAurora Parodi, Nicola Aste, Camilla Calvieri, et al.
The Journal of Dermatological Treatment|April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern ItalyStefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Plos One|November 3, 2020
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance studyLuigi Francesco Iannone, Luigi Bennardo, Caterina Palleria, et al.
Clinical Drug Investigation|July 1, 2010
Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuationAnnalisa Arcese, Nicola Aste, Alberta Bettacchi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Canadian Family Physician Medecin De Famille Canadien|December 17, 2008
Question: can you identify this condition?Claudio Guarneri, Giancarlo Valenti
Journal of Hospital Medicine|April 16, 2010
More than a plantar wartClaudio Guarneri, Giancarlo Valenti
Dermatology Reports|July 3, 2024
Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussionGaia Fasano, Giancarlo Valenti, Domenico D'Amico, et al.
Dermatologic Therapy|October 1, 2022
A severe case of IgA bullous pemphigoid successfully treated with dupilumabMario Valenti, Pierfrancesco De Giacomo, Annamaria Lavecchia, et al.
Clinical and Experimental Dermatology|April 25, 2026
Real-world efficacy and safety of Sonidegib in Locally Advanced and Multiple Basal Cell Carcinomas: A Monocentric Prospective Observational StudyChiara Del Re, Vincenzo Filastro, Gaia Fasano, et al.
American Journal of Clinical Dermatology|April 24, 2014
Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian populationAurora Parodi, Nicola Aste, Camilla Calvieri, et al.
The Journal of Dermatological Treatment|April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern ItalyStefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Plos One|November 3, 2020
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance studyLuigi Francesco Iannone, Luigi Bennardo, Caterina Palleria, et al.
Clinical Drug Investigation|July 1, 2010
Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuationAnnalisa Arcese, Nicola Aste, Alberta Bettacchi, et al.
Pageof 1